diphenyleneiodonium has been researched along with Coronary Artery Disease in 1 studies
diphenyleneiodonium: structure in first source; NADPH oxidase inhibitor
dibenziodolium : An organic cation that is fluorene in which the methylene group is replaced by a positively charged iodine.
Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cerrato, R | 1 |
| Cunnington, C | 1 |
| Crabtree, MJ | 1 |
| Antoniades, C | 1 |
| Pernow, J | 1 |
| Channon, KM | 1 |
| Böhm, F | 1 |
1 other study available for diphenyleneiodonium and Coronary Artery Disease
| Article | Year |
|---|---|
Endothelin-1 increases superoxide production in human coronary artery bypass grafts.
Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Aged; Coronary Artery Bypass; Coronary Arter | 2012 |